1 / 26

Childhood Leukemia International Consortium

Childhood Leukemia International Consortium. I4C – Barcelona - September 2011 Catherine Metayer, MD, PhD University of California, Berkeley. Outstanding Research Questions. What are the critical windows of exposure? What are the risk factors of rarer CL subtypes like AML, APL, T-cell ALL?

rian
Download Presentation

Childhood Leukemia International Consortium

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript


  1. Childhood Leukemia International Consortium I4C – Barcelona - September 2011 Catherine Metayer, MD, PhD University of California, Berkeley

  2. Outstanding Research Questions • What are the critical windows of exposure? • What are the risk factors of rarer CL subtypes like AML, APL, T-cell ALL? • Are the risk factors specific to CL cytogenetic/ molecular subtypes of ALL and AML, or other tumor characteristics? • What is the contribution of GxE interaction?

  3. Timing of Exposure to Tobacco Smoke Preconception -Paternal smoking -Maternal smoking Pregnancy - Maternal smoking Postnatal - Child’s passive smoking exposure Birth INITIATION PROMOTION

  4. Tobacco Smoke: Critical Windows of Exposure Conception Birth

  5. Meta-analyses on Impact of Paternal Preconception Smoking on CL Source: Epidemiology of parental smoking and childhood leukemia: Kang et al., 2008

  6. Molecular Subsets of ALL INFANTS CHILDREN

  7. Translocations Associated with ALL: TEL-AML1 Gene Fusion • Occurs in approximately 20-25% of patients with ALL (cALL) with peak incidence between ages 2 – 5 years. • Strong evidence that this occurs in utero. • Frequency of this translocation at birth is 100-fold greater than the risk of developing the corresponding leukemia. Source: Greaves, BMJ, 2002.

  8. CLIC - History • 2005 Meeting at IARC to introduce the concept • 2006 First informal meeting with PIs from Australia, France, Canada, and US-California • 2007 First grant from the US National Cancer Institute to support the proof of principle of pooled analysis on folate & MTHFR and risk of CL • >2007 Additional support from the Children with Cancer, UK & the NIEHS and EPA, US (since 2009)

  9. CLIC Mission • Develop and support collaborations between scientists involved in CL research to accelerate knowledge on factors that influence the risk of childhood leukemia through epidemiological studies and related research • Encourage free exchange of results (published or unpublished) and ideas in a collegial environment without fear of competition

  10. 22 CLIC Studies UKCCS(Roman) Manchester, UK(Birch/Taylor) CCRG, UK(Murphy) GCCR(Kaatsch/Schüz) Germany(Grosche, Ziegelberger) Italy(Magnani) Japan(Manabe, Mizutani) NCCLS(Buffler) COG(Spector) Texas(Bondy) Greece(Petridou) Quebec(Infante-Rivard) St. Justine(Sinnett) France(Clavel) Seoul(Kang) Costa Rica(Monge) Brazil-IAL(Pombo-de-Oliveira) AUS-ALL(Armstrong/Milne) New Zealand(Dockerty) 22 Studies, 13 Countries Red = New Member Countries in 2009 Green = Countries in planning phase to start study on childhood leukemia

  11. CLIC Studies • ~10,000 leukemia cases and 15,000 controls • ~50% studies with biospecimens • Study period from mid-70’s to 2011 • Common scientific interest

  12. Website clic.berkeley.edu

  13. CLIC Interest Groups • AML/APL • Environmental Exposure • Family History • Genetics • Infant Leukemia • Infection and Immunity • Occupational Exposures • Outcomes

  14. CLIC Procedures Call for Expression of Interest Full Proposal and Agreement of Pooled Analyses Data Transfer

  15. Ongoing Pooled Analyses • Fetal growth and risk of childhood ALL • Vitamin/folate supplementation before and during pregnancy, MTHFR variants and risk of childhood ALL and AML • Parental smoking, NQ01 gene, and risk of childhood ALL

  16. Proposed Pooled Analyses • Markers of childhood infections and allergies and of ALL • Geographical of distribution of AML cytogenetic type, including APL • Indoor sources of benzene and other hydrocarbons (i.e., parental smoking, home use of paint/solvent, type of heating), NQ01 gene, and risk of AML

  17. Proposals Under Development • Residential use of pesticides and risk of childhood ALL and AML • Residential use of paint/solvent and risk of childhood ALL • SES, environmental and genetic determinants and CL survival in CLIC studies

  18. Challenges • Study specificity regarding prevalence of exposure, design, confounders (SES, ethnicity, etc…) • Meta-data analyses vs. pooling of raw data • Recognize potential for selection bias in observational studies that require subject consent, and attempt to assess the representativeness of participating families

  19. Pooling of Vitamin/Folate data(7624 cases/11459 controls)

  20. Study Period and Vitamin/Folate Recommendation WHO recommendation of 0.4mg/day of folate

  21. Prevalence of Vitamin Use

  22. Prevalence of Folate Use

  23. CLIC Database Infrastructure • Web-based inventory under development • Surveys for availability of biospecimen, genetic, and cytogenetic data • Seek additional funding to complete and maintain CLIC inventory, centralized database of common variables, and data repository

  24. Opportunities of Collaborations Between CLIC and I4C • Exchanges of ideas • Genetic and epigenetic studies • Emerging hypotheses such as parental smoking • Exposure assessment in cohort studies that could inform case-control studies • Ethical issues • Exchanges of procedures • Standardize data • Compile background information on exposure pattern by country and overtime

  25. Acknowledgments • Pat Buffler and colleagues at the UC Berkeley-based California Childhood Leukemia Study • Colleagues at CLIC, especially other founding Members L. Milne (Australia), C. Infante-Rivard (Canada), and J. Clavel (France) • Colleagues and sponsors at the National Cancer Institute • Other sponsors in the US (NIEHS, EPA) and UK (Children with Cancer) • Families and clinicians

  26. Thank you

More Related